- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05907148
Effects of Sensory Integration Training on Balance and Confidence in Patients With Parkinson's Disease
The Objective of this research was to study the effectiveness of sensory integration training on balance and confidence in patients with Parkinson's disease.
Null Hypothesis:
Sensory integration training and conventional balance training have no significant difference in improving balance and confidence of patients with Parkinson's disease.
Alternative Hypothesis:
Sensory integration training and conventional balance training have a significant difference in improving balance and confidence in patients with Parkinson's disease.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study design will be randomized controlled clinical trial. Patients who fulfill the inclusion criteria will be identified by individual physiotherapist and will be enrolled for particular study. A sample size of 46 patients will be taken in this study by expecting a mean change 10.42 using 80% power of study and 95% level of significance and 20% dropout will also be included. So each group contains 23 participants.
The study will be single blinded. The outcome assessor will be unaware of the treatment given to both groups. Sample will be collected through simple random sampling technique, and randomization sequencing will be generated with help of lottery. After selection the sample patients will be divided into two groups, allocation concealment will be ensured by using sealed envelopes. Group A will be given conventional balance training along with routine physical therapy without sensory integration and Group B will be given sensory integration physical therapy along with routine physical therapy. Group A will be called control group and Group B will be called experimental group. Every patient has to pick up an envelope which will be placed in patient's file which later will be opened by the researcher who will provide patient treatment accordingly.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Momna Asghar, MsPTN
- Phone Number: +92336249488
- Email: momna2april@gnmail.com
Study Locations
-
-
Punjab
-
Lahore, Punjab, Pakistan
- Recruiting
- ganga Raam Hopital
-
Contact:
- Arooj Munawar, PHD
- Email: arooj.munawar@uipt.uol.edu.pk
-
Principal Investigator:
- Abdul Majid shahid
-
Lahore, Punjab, Pakistan
- Recruiting
- the Univerity of Lahore Teaching hospital
-
Contact:
- momna asghar, mspt
- Phone Number: +923047487795
- Email: momna2april@gmail.com
-
Principal Investigator:
- Abdul Majid shahid, DPT
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Male and female patients diagnosed by a neurologist with Parkinson's disease.
- Patients having BBS score between 21-40
- At least 6 months post neurological Sensory/Motor deficit patient.
- Age between 30 -65 years.
- Ability to maintain standing position without aids for at least 5 minutes.
- Normal vision
- No severe systemic disorders
- An ability to understand and perform the test
Exclusion Criteria:
- Patients with other existing neuromuscular disorders or medical conditions that substantially influences their gait and balance performance
- Neuropathy patients
- Vestibular disorders, paroxysmal vertigo.
- Presence of orthopedic conditions involving the lower limbs.
- Patients with psychiatric disorders.
- Pregnant patients.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Routine Physical therapy along with Coordination exercises
The Control group training will consist of active joint mobilization, muscle stretching, motor coordination exercises and additionally will receive 30-minute general balance training.
Active joint mobilization will be carried out with the patient in the supine, prone (if possible), or sitting positions.
Muscle stretching will be carried out mainly in the supine, prone (if possible), and standing positions.
Motor coordination exercises will be carried out in a supine position, sitting and standing positions.
|
It consist of active joint mobilization, muscle stretching, motor coordination exercises and general balance training
Other Names:
In supine lying:
In sitting:
In standing: Patient performs 10 repetitions of
|
|
Experimental: sensory Integration training group along with Routine physical therapy
experimental group training will consist of active joint mobilization, muscle stretching, motor coordination exercises and additionally 30 minutes of sensory integration therapy.
|
It consist of active joint mobilization, muscle stretching, motor coordination exercises and general balance training
Other Names:
Sitting position:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Berg Balance Scale (BBS):
Time Frame: the change in the ability to balance in individual at baseline, 6th and 12th week
|
The BBS is a 14-item validated scale that assesses static and dynamic Balance disorders in individuals with Parkinson's disease (score range, 0-56; higher=better performance).
The items explore the ability to sit, stand, lean, turn, and maintain the upright position on one leg.
Performance of these tasks depends on central integration processes to select specific response strategies which, in turn, depend on the characteristics of external postural displacement and goals
|
the change in the ability to balance in individual at baseline, 6th and 12th week
|
|
Activities-specific Balance Confidence Scale (ABC):
Time Frame: the change in the ability to balance in individual at baseline, 6th and 12th week
|
This validated and reliable self-reported measure evaluates the patient's perceived level of balance confidence in performing various ambulatory activities without falling or experiencing a sense of instability.
The overall score is calculated by adding the item scores and then dividing by the total number of items (score range, 0-100 points per activity; higher=more confident.
|
the change in the ability to balance in individual at baseline, 6th and 12th week
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- REC-UOL-367-04-2023
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
Bezmialem Vakif UniversityRecruitingParkinson Disease | Parkinson | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseTurkey (Türkiye)
-
CND Life SciencesDigestive Disease Associates of CTRecruitingParkinson Disease | Parkinson | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Neuron23 Inc.Roche Diagnostic Ltd.; Qiagen Manchester LimitedRecruitingParkinson Disease | Parkinson | Idiopathic Parkinson Disease | Parkinson Disease, Idiopathic | Early Parkinson Disease (Early PD)United States, Spain, Israel, Poland, Italy, United Kingdom
-
San Francisco Neurology and Sleep CenterNot yet recruitingPARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Haukeland University HospitalUniversity of Bergen; SPARK NSRecruitingParkinson Disease (PD) | Parkinson s DiseaseNorway
-
CND Life SciencesOregon Health and Science UniversityRecruitingParkinson Disease | Parkinson | Parkinson's Disease and Parkinsonism | PARKINSON DISEASE (Disorder)United States
-
Università degli Studi dell'InsubriaUniversidade Nova de Lisboa; Associazione Parkinson Insubria (AsPI), Section... and other collaboratorsRecruitingParkinson Disease | Parkinson | Parkinson Disease, Idiopathic | PARKINSON DISEASE (Disorder)Italy
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
Duke UniversityMedical University of South Carolina; Massachusetts General Hospital; Mayo Clinic and other collaboratorsNot yet recruitingGut Microbiota | Gut Microbiome | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Prodromal Parkinsons DiseaseUnited States
-
ProgenaBiomeWithdrawnParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
Clinical Trials on Routine physical therapy
-
Riphah International UniversityCompleted
-
Riphah International UniversityCompleted
-
University of LahoreRecruitingMild Traumatic Brain InjuryPakistan
-
Riphah International UniversityCompletedCerebral PalsyPakistan
-
University of LahoreRecruitingChronic Hemorrhagic StrokePakistan
-
University of LahoreRecruitingHemiplegic Cerebral PalsyPakistan
-
Riphah International UniversityCompleted
-
Riphah International UniversityEnrolling by invitation
-
University of LahoreCompleted
-
University of LahoreRecruiting